MENU
+Compare
ENLV
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$1.00
Change
-$0.02 (-1.96%)
Capitalization
21.99M

ENLV Enlivex Therapeutics Ltd Forecast, Technical & Fundamental Analysis

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ENLV with price predictions
Feb 20, 2025

ENLV's Stochastic Oscillator dives oversold zone

The Stochastic Oscillator for ENLV moved into oversold territory on February 20, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ENLV's RSI Oscillator exited the oversold zone, of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

ENLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ENLV as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ENLV turned negative on January 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

ENLV moved below its 50-day moving average on January 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ENLV crossed bearishly below the 50-day moving average on January 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ENLV entered a downward trend on February 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.827) is normal, around the industry mean (12.644). P/E Ratio (0.000) is within average values for comparable stocks, (84.748). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.591). ENLV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (254.739).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ENLV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ENLV is expected to report earnings to -15 cents per share on February 26

Enlivex Therapeutics Ltd ENLV Stock Earnings Reports
Q4'24
Est.
$-0.16
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.03
Q1'24
Est.
$-0.25
Q4'23
Missed
by $0.21
The last earnings report on December 02 showed earnings per share of -15 cents, beating the estimate of -19 cents. With 42.70K shares outstanding, the current market capitalization sits at 21.99M.
A.I. Advisor
published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 26208072
Employees
77
Web
https://www.enlivex.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPH31.270.38
+1.23%
Tri Pointe Homes
IX101.680.26
+0.26%
ORIX Corp
EFC13.120.02
+0.15%
Ellington Financial
RMBL4.11-0.04
-0.96%
RumbleOn
TENX6.13-0.57
-8.51%
Tenax Therapeutics

ENLV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENLV
1D Price
Change %
ENLV100%
-3.01%
APVO - ENLV
37%
Loosely correlated
-1.16%
FATE - ENLV
32%
Poorly correlated
-9.65%
VKTX - ENLV
30%
Poorly correlated
-2.04%
SLNO - ENLV
29%
Poorly correlated
-0.13%
AXON - ENLV
29%
Poorly correlated
-8.70%
More